Kirsty (previously Kixelle)

Country: European Union

Language: Dutch

Source: EMA (European Medicines Agency)

Buy It Now

Patient Information leaflet Patient Information leaflet (PIL)
01-12-2023
Summary of Product characteristics Summary of Product characteristics (SPC)
01-12-2023
Public Assessment Report Public Assessment Report (PAR)
14-09-2021

Active ingredient:

insuline aspart

Available from:

Biosimilar Collaborations Ireland Limited

ATC code:

A10AB05

INN (International Name):

insulin aspart

Therapeutic group:

Geneesmiddelen die worden gebruikt bij diabetes

Therapeutic area:

Suikerziekte

Therapeutic indications:

Kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Product summary:

Revision: 4

Authorization status:

Erkende

Authorization date:

2021-02-05

Patient Information leaflet

                                SERVER ERROR 404 - FILE OR DIRECTORY NOT FOUND. THE RESOURCE YOU ARE LOOKING FOR MIGHT HAVE BEEN REMOVED, HAD ITS
NAME CHANGED, OR IS TEMPORARILY UNAVAILABLE.
                                
                                Read the complete document

Summary of Product characteristics

                                SERVER ERROR 404 - FILE OR DIRECTORY NOT FOUND. THE RESOURCE YOU ARE LOOKING FOR MIGHT HAVE BEEN REMOVED, HAD ITS
NAME CHANGED, OR IS TEMPORARILY UNAVAILABLE.
                                
                                Read the complete document

Similar products

Active ingredient insuline aspart

insuline aspart

ATC code A10AB05

A10AB05

Marketed by Biosimilar Collaborations Ireland Limited

Biosimilar Collaborations Ireland Limited

INN (International Name) insulin aspart

insulin aspart

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Bulgarian 01-12-2023
Public Assessment Report Public Assessment Report Bulgarian 14-09-2021
Patient Information leaflet Patient Information leaflet Spanish 01-12-2023
Summary of Product characteristics Summary of Product characteristics Spanish 01-12-2023
Public Assessment Report Public Assessment Report Spanish 14-09-2021
Patient Information leaflet Patient Information leaflet Czech 01-12-2023
Summary of Product characteristics Summary of Product characteristics Czech 01-12-2023
Public Assessment Report Public Assessment Report Czech 14-09-2021
Patient Information leaflet Patient Information leaflet Danish 01-12-2023
Summary of Product characteristics Summary of Product characteristics Danish 01-12-2023
Public Assessment Report Public Assessment Report Danish 14-09-2021
Patient Information leaflet Patient Information leaflet German 01-12-2023
Summary of Product characteristics Summary of Product characteristics German 01-12-2023
Public Assessment Report Public Assessment Report German 14-09-2021
Patient Information leaflet Patient Information leaflet Estonian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Estonian 01-12-2023
Public Assessment Report Public Assessment Report Estonian 14-09-2021
Patient Information leaflet Patient Information leaflet Greek 01-12-2023
Summary of Product characteristics Summary of Product characteristics Greek 01-12-2023
Public Assessment Report Public Assessment Report Greek 14-09-2021
Patient Information leaflet Patient Information leaflet English 01-12-2023
Summary of Product characteristics Summary of Product characteristics English 01-12-2023
Public Assessment Report Public Assessment Report English 14-09-2021
Patient Information leaflet Patient Information leaflet French 01-12-2023
Summary of Product characteristics Summary of Product characteristics French 01-12-2023
Public Assessment Report Public Assessment Report French 14-09-2021
Patient Information leaflet Patient Information leaflet Italian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Italian 01-12-2023
Public Assessment Report Public Assessment Report Italian 14-09-2021
Patient Information leaflet Patient Information leaflet Latvian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Latvian 01-12-2023
Public Assessment Report Public Assessment Report Latvian 14-09-2021
Patient Information leaflet Patient Information leaflet Lithuanian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Lithuanian 01-12-2023
Public Assessment Report Public Assessment Report Lithuanian 14-09-2021
Patient Information leaflet Patient Information leaflet Hungarian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Hungarian 01-12-2023
Public Assessment Report Public Assessment Report Hungarian 14-09-2021
Patient Information leaflet Patient Information leaflet Maltese 01-12-2023
Summary of Product characteristics Summary of Product characteristics Maltese 01-12-2023
Public Assessment Report Public Assessment Report Maltese 14-09-2021
Patient Information leaflet Patient Information leaflet Polish 01-12-2023
Summary of Product characteristics Summary of Product characteristics Polish 01-12-2023
Public Assessment Report Public Assessment Report Polish 14-09-2021
Patient Information leaflet Patient Information leaflet Portuguese 01-12-2023
Summary of Product characteristics Summary of Product characteristics Portuguese 01-12-2023
Public Assessment Report Public Assessment Report Portuguese 14-09-2021
Patient Information leaflet Patient Information leaflet Romanian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Romanian 01-12-2023
Public Assessment Report Public Assessment Report Romanian 14-09-2021
Patient Information leaflet Patient Information leaflet Slovak 01-12-2023
Summary of Product characteristics Summary of Product characteristics Slovak 01-12-2023
Public Assessment Report Public Assessment Report Slovak 14-09-2021
Patient Information leaflet Patient Information leaflet Slovenian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Slovenian 01-12-2023
Public Assessment Report Public Assessment Report Slovenian 14-09-2021
Patient Information leaflet Patient Information leaflet Finnish 01-12-2023
Summary of Product characteristics Summary of Product characteristics Finnish 01-12-2023
Public Assessment Report Public Assessment Report Finnish 14-09-2021
Patient Information leaflet Patient Information leaflet Swedish 01-12-2023
Summary of Product characteristics Summary of Product characteristics Swedish 01-12-2023
Public Assessment Report Public Assessment Report Swedish 14-09-2021
Patient Information leaflet Patient Information leaflet Norwegian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Norwegian 01-12-2023
Patient Information leaflet Patient Information leaflet Icelandic 01-12-2023
Summary of Product characteristics Summary of Product characteristics Icelandic 01-12-2023
Patient Information leaflet Patient Information leaflet Croatian 01-12-2023
Summary of Product characteristics Summary of Product characteristics Croatian 01-12-2023
Public Assessment Report Public Assessment Report Croatian 14-09-2021

Search alerts related to this product

Alerts Kirsty insuline aspart

Kirsty insuline aspart

View documents history

Documents history Documents history

Kirsty (previously Kixelle)